Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B in children.

Annemarie L Broderick1, Maureen M Jonas

  • 1Gastroenterology and Nutrition, Division of Gastroenterology, Department of Medicine, Children's Hospital, Boston, Massachusetts, USA.

Seminars in Liver Disease
|March 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Cross-Sectional Retrospective Review of Neuropsychiatric Comorbidities in Children With Non-Alcoholic Fatty Liver Disease.

Clinical pediatrics·2025
Same author

Sofosbuvir-velpatasvir in children 3-17 years old with hepatitis C virus infection.

Journal of pediatric gastroenterology and nutrition·2024
Same author

ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource-limited settings.

Journal of pediatric gastroenterology and nutrition·2024
Same author

Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study.

Hepatology communications·2023
Same author

Presentation, Management, and Outcome of Congenital Portosystemic Shunts in Children: The Boston Children's Hospital Experience.

Journal of pediatric gastroenterology and nutrition·2022
Same author

Utilization of the Boston Children's Hospital SRTR Cohort Visualization Tool to increase team understanding of reporting cohorts.

Pediatric transplantation·2021
Same journal

Endothelial Cell Therapy for the Acute and Chronic Liver Disease.

Seminars in liver disease·2026
Same journal

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Seminars in liver disease·2026
Same journal

Expert Practical Recommendations for Hepatocellular Carcinoma.

Seminars in liver disease·2026
Same journal

Optimizing Liver Cancer Care Through BCLC Principles.

Seminars in liver disease·2026
Same journal

Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.

Seminars in liver disease·2026
Same journal

Practical Guide to Best Practices in Alcohol-Associated Liver Disease.

Seminars in liver disease·2026
See all related articles

Childhood hepatitis B virus (HBV) infection poses significant risks, with infants facing a 90% chance of chronic infection. Universal infant vaccination is key to reducing HBV

Area of Science:

  • Pediatric Hepatology
  • Virology
  • Public Health

Background:

  • Childhood hepatitis B virus (HBV) infection presents unique medical and public health challenges.
  • Infants infected perinatally have a high risk (up to 90%) of developing chronic HBV.
  • Many infected children are asymptomatic with normal liver enzymes, yet risk chronic liver disease or cancer.

Purpose of the Study:

  • To review aspects of hepatitis B virus infection unique to or different in children.
  • To discuss the evolving optimal treatment strategies for chronic HBV in pediatric populations.
  • To highlight the importance of vaccination in managing childhood HBV.

Main Methods:

  • Literature review of pediatric HBV infection.
  • Analysis of treatment options including interferon-alfa and lamivudine.

Related Experiment Videos

  • Evaluation of vaccination impact on HBV prevalence.

    • Main Results:

    • Chronic HBV infection in children often presents with minimal symptoms and normal liver enzymes.
    • Interferon-alfa and lamivudine are available treatments, but optimal use is still being determined.
    • Universal infant vaccination significantly reduces HBV infection rates and long-term complications.

    Conclusions:

    • Childhood HBV infection requires specialized medical and public health approaches.
    • Understanding treatment indications, timing, efficacy, and side effects is crucial for pediatric HBV management.
    • Infant vaccination remains the most effective strategy for preventing childhood HBV infection and its sequelae.